Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormonal replacement therapy and inflammatory response--update].

D Zeltser1, S Berliner, I Shapira

  • 1Department of Medicine D, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv.

Harefuah
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.

Neurogastroenterology and motility·2017
Same author

Assessing fatigue in inflammatory bowel disease: comparison of three fatigue scales.

Alimentary pharmacology & therapeutics·2015
Same author

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.

British journal of cancer·2013
Same author

Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations.

Psychological medicine·2013
Same author

Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.

European journal of neurology·2013
Same author

Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome.

Neurogastroenterology and motility·2011
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Hormonal replacement therapy (HRT) may increase C-reactive protein (CRP), a marker of inflammation. This could lead to a higher risk of vascular diseases and blood clots in postmenopausal women.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Inflammation Research

Context:

  • Postmenopausal hormone replacement therapy (HRT) is widely used.
  • Elevated C-reactive protein (CRP) is a known marker of inflammation.
  • Increased CRP is linked to adverse cardiovascular outcomes.

Purpose:

  • To investigate the association between HRT and CRP levels.
  • To explore the implications of HRT-induced CRP elevation on vascular health.
  • To assess the potential risks of HRT in women with pre-existing inflammatory or thrombophilic conditions.

Summary:

  • Studies suggest HRT administration may correlate with increased CRP concentrations in postmenopausal women.
  • Elevated CRP, an inflammatory marker, is associated with unfavorable outcomes like ischemic vascular diseases and accelerated atherosclerosis.

Related Experiment Videos

  • HRT use may also enhance thrombotic tendency, potentially increasing risks in susceptible individuals.

    • Impact:

    • HRT administration in women with elevated inflammatory markers (e.g., CRP) or thrombophilic factors may lead to less favorable clinical outcomes.
    • This highlights the need for careful patient selection and risk assessment before initiating HRT.
    • Further research is warranted to elucidate the mechanisms and clinical significance of these associations.